Department of Pediatric Rheumatology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.
Department of Pediatric Nephrology, Ankara University School of Medicine, Ankara, Turkey.
Mod Rheumatol. 2021 Nov;31(6):1142-1147. doi: 10.1080/14397595.2021.1886892. Epub 2021 Mar 1.
The aims of this study were to describe the clinical features, comorbidities and outcome of systemic childhood polyarteritis nodosa (PAN) and to evaluate PAN-like diseases in differential diagnosis.
The study group consisted of patients who were diagnosed as PAN in a referral center in Turkey. The files of all patients were reviewed retrospectively. Disease activity was evaluated with pediatric vasculitis activity score (PVAS).
A total of 19 (13 boys/six girls) patients were enrolled in the study. The mean age of patients was 10.37 ± 3.6 years. The mean duration of follow-up was 5.73 ± 3.74 years. Eight patients (42.1%) were also diagnosed with familial Mediterranean fever (FMF). The cutaneous involvement was higher in patients with PAN than those with FMF-associated PAN ( = .03). The median (min-max) PVAS at diagnosis was 5 (3-7). There was no correlation between PVAS scores at the time of diagnosis and age, clinical findings and relapse. CECR1 mutation was detected in one patient leading to deficiency of adenosine deaminase 2.
The clinical presentation is variable in children with PAN. PAN-like diseases characterized by necrotizing vasculitis should be considered. The possibility of FMF should be kept in mind if inflammation cannot be controlled.
本研究旨在描述儿童系统性结节性多动脉炎(PAN)的临床特征、合并症和预后,并评估鉴别诊断中的 PAN 样疾病。
研究组由在土耳其转诊中心被诊断为 PAN 的患者组成。回顾性审查所有患者的档案。采用儿科血管炎活动评分(PVAS)评估疾病活动度。
共纳入 19 名(13 名男性/6 名女性)患者。患者的平均年龄为 10.37±3.6 岁。平均随访时间为 5.73±3.74 年。8 名患者(42.1%)还被诊断为家族性地中海热(FMF)。PAN 患者的皮肤受累高于 FMF 相关 PAN 患者( = .03)。诊断时的中位(最小-最大)PVAS 为 5(3-7)。诊断时的 PVAS 评分与年龄、临床发现和复发之间无相关性。在一名患者中检测到 CECR1 突变,导致腺苷脱氨酶 2 缺乏。
儿童 PAN 的临床表现多种多样。应考虑以坏死性血管炎为特征的 PAN 样疾病。如果炎症无法控制,应考虑 FMF 的可能性。